159 related articles for article (PubMed ID: 2733455)
1. Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.
Selleri L; Emilia G; Temperani P; Grassilli E; Zucchini P; Tagliafico E; Bonati A; Venezia L; Ferrari S; Torelli U
Leukemia; 1989 Jul; 3(7):538-42. PubMed ID: 2733455
[TBL] [Abstract][Full Text] [Related]
2. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
4. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
7. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
8. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
10. Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemia.
Tesch H; Fonatsch C; Diehl V
In Vivo; 1991; 5(3):233-8. PubMed ID: 1893079
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
12. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis.
Price CM; Foadi MD; Morgan GJ; Wiedemann LM
Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347
[TBL] [Abstract][Full Text] [Related]
15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
16. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
18. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
19. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
